| dc.contributor.author | Ahmed, Ashraqat | |
| dc.date.accessioned | 2022-08-21T10:37:33Z | |
| dc.date.available | 2022-08-21T10:37:33Z | |
| dc.date.issued | 2022-08-16 | |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/3933 | |
| dc.description.abstract | In preclinical and clinical research, oncolytic virotherapy has
yielded promise but limited results. Induction of tumor-specific
immunity is an important therapeutic mechanism of oncolytic
virotherapy, in addition to direct oncolytic activity. As a result,
the insertion of immune stimulator genes and sensible
combinatorial therapy with other immunotherapies can boost
the efficacy of oncolytic viruses. | en_US |
| dc.publisher | Libyan International Medical University Faculty of AMS | en_US |
| dc.title | Oncolytic Viruses for Cancer Immunotherapy | en_US |
| dc.title.alternative | Oncolytic Viruses for Cancer Immunotherapy | en_US |
| dc.type | Other | en_US |
